Skip to content

Research on the screening of biomarkers for AKI after surgery in patients with RCC-IVCTT based on Ion Chromatography and GC-MS

Research on the screening of biomarkers for AKI after surgery in patients with RCC-IVCTT based on Ion Chromatography and GC-MS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089467
Enrollment
Unknown
Registered
2024-09-09
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cell Carcinoma complicated with Inferior Vena Cava Tumor Thrombus

Interventions

AKI group/ Non AKI group:None

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who visited our center and were diagnosed with RCC-IVCTT (Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus); Patients who are older than 18 years of age; Patients or their legal representatives understand the study and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: Patients who have not undergone RN-IVCT surgery; Patients with malignancies in other systems; Patients with stones or cysts in their healthy kidney; Patients with bilateral kidney tumors; Patients who were lost to follow-up.

Design outcomes

Secondary

MeasureTime frame
blood urea nitrogen;thrombocyte;whether there are other underlying diseases;Enhanced renal MRI examination;

Primary

MeasureTime frame
serum creatinine and urine volume;

Countries

China

Contacts

Public ContactMa Xin

Department of Urology, Chinese PLA General Hospital

mxin301@126.com+86 166 2935 1458

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026